Articles tagged with Chronic Obstructive Pulmonary Disease
A study of nearly 9,000 patients found that African-Americans are less likely than whites to have had a prior diagnosis of chronic obstructive pulmonary disease (COPD), regardless of their current disease severity. In contrast, women are more likely than men to have been diagnosed with COPD, even in the absence of airflow obstruction.
A study of older patients with chronic obstructive pulmonary disease (COPD) found that new use of long-acting bronchodilators was associated with an increased risk of cardiovascular events. The study suggests that close monitoring of COPD patients taking these medications is necessary to mitigate this risk.
A new device, Lung Volume Reduction Coil (LVRC), has shown significant improvements in lung function, ability to exercise, and quality of life for patients with severe emphysema. The device, implanted through a minimally invasive procedure, gathered and compressed diseased lung tissue, allowing healthy tissue to function more efficiently.
A population-based study found that exposure to both wood smoke and tobacco smoke significantly increases the risk of developing chronic obstructive pulmonary disease (COPD) and experiencing more frequent and severe symptoms. The study also found that those exposed to both types of smoke had poorer lung function scores and more phlegm,...
A new study has identified risk factors for depression among COPD patients, including female patients and those experiencing significant shortness of breath. The study found that physical activity was a protective factor against depression, with patients who had higher levels of physical activity less prone to developing depression.
Research reveals that COPD patients with allergic disease experience worsened respiratory symptoms and increased risk of exacerbations. These findings suggest that addressing allergic disease may help improve respiratory health in COPD patients, according to a new study.
Researchers from BUSM have developed a genetic signature for COPD from airway cells, providing a new way to study the disease and monitor patient response to treatments. This approach has shown consistent gene-expression changes in both airway and lung tissue cells in individuals with COPD.
A new nuclear medicine technique can detect early changes to the lung caused by cigarette smoke exposure, providing a noninvasive method for studying lung dysfunction in preclinical models. This technique has the potential to be applied clinically to study and diagnose the early stages of COPD.
Researchers from RIKEN Advanced Science Institute have identified Siglec-14 as a protein involved in the exacerbation of chronic obstructive pulmonary disease (COPD). Patients without this protein are less susceptible to exacerbation, suggesting potential new targets for treatment. The study's findings imply that personalized care base...
A study published in The BMJ found that long-term use of clarithromycin, a commonly used antibiotic for lower respiratory tract infections, may be associated with an increased risk of heart problems. The research, which analyzed data from over 1,300 patients, suggests that there will be an additional cardiovascular event for every eigh...
A new study investigates the role of protein kinase C (PKC) in airway smooth muscle contraction, revealing its potential as a therapeutic target for treating asthma and chronic obstructive pulmonary disease (COPD). The research suggests that PKC activation could contribute to airway hyperresponsiveness and exacerbate lung diseases.
Scientists at the University of Pennsylvania School of Medicine have discovered a way to repair lung damage caused by asthma and chronic obstructive pulmonary disease (COPD) by tweaking gene expression. They found that epigenetic regulators, including HDAC2, play a critical role in regulating lung development and regeneration.
A new study has found that bronchiectasis is independently associated with an increased mortality risk in patients with moderate-to-severe Chronic Obstructive Pulmonary Disease (COPD). The presence and severity of bronchiectasis were linked to a higher risk of death, independent of other known risk factors.
A study found that more than a third of adults with COPD were prescribed benzodiazepines, despite warnings about their potential harm. The most vulnerable group, those with severe COPD, used the medication at the highest frequency and with the most repeat prescriptions.
A Norwegian study found that emphysema severity is a strong predictor of all-cause and cardiovascular mortality in ever-smokers with or without COPD. The study also showed that airway wall thickness is associated with respiratory mortality in patients with severe emphysema.
A recent study published in the Journal of Thoracic Oncology found that COPD is not an independent risk factor for lung cancer. Researchers associated COPD with lung cancer, but attributed this link to smoking and ascertainment bias, highlighting the need for lung cancer screenings when diagnosing COPD.
Researchers have designed new drugs that inhibit excess mucus production in airway cells, a major cause of death in respiratory conditions like asthma and COPD. The drugs target the MAPK13 protein, which is involved in the mucus pathway and can reduce mucus production by 100 fold.
The study provides the first report of state-level COPD prevalence, revealing significant regional variations. Nationwide, 6% of non-institutionalized adults reported having COPD, with higher prevalence in select states.
The UK BiLEVE study aims to discover the genes affecting lung function and susceptibility to COPD. Researchers will analyze data from 50,000 UK Biobank participants to identify genetic variants associated with COPD, shedding light on why some people are more prone to lung disease.
Dr. Richard Casaburi leads research on COPD, a disease affecting millions, to identify genetic factors and develop new treatments. The study, funded by NIH, aims to understand what genetic deficiencies contribute to COPD development and progression.
Researchers have discovered that older COPD patients are more likely to develop high-risk carotid artery plaque formations and have a greater presence of vulnerable plaques with a lipid core. This finding highlights the increased risk of ischemic events in these patients.
Researchers developed a new X-ray technology that analyzes scattered radiation to detect emphysema in lungs. This technology helps identify disease progression and localization, aiding early diagnosis and treatment of Chronic Obstructive Pulmonary Disease (COPD).
Researchers found that Asian Americans, college graduates, and moderate drinkers (1-2 drinks/day) had a lower risk for chronic obstructive pulmonary disease (COPD). Despite powerful predictors of COPD including smoking, age, and respiratory history, these groups showed a moderately lower risk, suggesting new targets for therapy.
A new study suggests that COPD readmissions are more common among patients with advanced disease, congestive heart failure, coronary artery disease, alcohol abuse, or those using supplemental oxygen. Researchers found these unmodifiable risk factors to be associated with a higher likelihood of 30-day readmission.
A simple 5-question patient-administered survey (COPD-PS) may lead to increased COPD diagnoses. The study found that screening tools in primary care could facilitate diagnosis of COPD in this population.
A study by multiple institutions found that roflumilast increased lung function in moderate and severe COPD patients, with significant improvements in FEV1 after 6 months. Roflumilast was compared to placebo, showing consistent increases in lung function across treatment groups.
Research by CDC reveals disparities in COPD mortality by state, poverty level, and urban vs. rural location, with poorest outcomes seen in rural and poor communities. Smoking prevalence, air quality, and access to healthcare are key contributing factors to these disparities.
A new approach to lung scanning, called parametric response mapping, allows for better distinction between early-stage small airway disease and emphysema in patients with chronic obstructive pulmonary disease (COPD). The technique enables precise diagnosis and treatment planning, as well as tracking COPD progression over time.
Patients with COPD report fatigue, sleepiness, and impaired quality of life due to poor sleep quality. The study found an association between daytime hypoxemia and sleep efficiency in COPD patients.
A multicenter trial found that antibiotic treatment with amoxicillin/clavulanate significantly improved clinical cure rates and prolonged the median time to next exacerbation in patients with mild-to-moderate COPD. Patients with elevated capillary C-reactive protein (CRP) levels were more likely to be cured without antibiotics.
A review article highlights the role of interleukin-18 (IL-18) in inflammation and its potential as a therapeutic target for pulmonary inflammatory diseases. Therapies blocking IL-18 activity may offer effective treatment options for conditions like bronchial asthma and COPD.
A new study found that smoking history, specifically pack-years, can predict mortality in people with COPD. The researchers analyzed 208 participants and identified age, pack-years, and emphysema area as strong predictors of mortality.
A new study found that e-cigarette use caused a significant increase in airway resistance, lasting for 10 minutes, regardless of health status. The research suggests that e-cigarettes may be more harmful than marketed, highlighting the need for further investigation.
A new study reveals a significant prevalence of respiratory problems among people aged 85 years and over, with 20% of men and 21% of women having asthma or COPD. The study highlights the growing need for healthcare professionals to understand the challenges faced by this rapidly aging population.
A study led by BUSM researchers has found that the compound Gly-His-Lys (GHK) may halt the progression of emphysema and reverse some of its damage. The study demonstrates potential impact of genomic technologies in identifying new treatments for diseases using existing drugs and compounds.
A study published in Genome Medicine identified genes whose activity is altered with increasing lung damage. The compound Gly-His-Lys (GHK) was found to affect the activity of these genes and restore normal gene activity, repairing cell function in human cells from lungs damaged by emphysema.
The COPD Foundation and Brigham and Women's Hospital have launched the second phase of the COPDGene project, a comprehensive study analyzing the human genome to identify genetic predispositions to developing COPD. The study aims to develop specific treatments that could prevent disease progression and improve quality of life for indivi...
A team from MSU's College of Osteopathic Medicine applies four osteopathic manipulative treatments to patients with moderate to severe COPD. The study aims to determine the biochemical changes in patients' blood following manipulation and correlate it with pulmonary function.
A new study found that Tai Chi can improve exercise capacity and quality of life in people with chronic obstructive pulmonary disease (COPD). The study, published in the European Respiratory Journal, suggests that Sun-style Tai chi may be as beneficial as pulmonary rehabilitation.
A multidisciplinary team from VCU suggests a three-times-a-week dose of azithromycin may benefit patients with COPD by eliminating one-third of severe exacerbations each year. However, the approach carries potential risks such as hearing loss and antibiotic resistance.
Chronic obstructive pulmonary disease (COPD) increases lung cancer risk through a novel mechanism involving long-term oxygen depletion and HIF-2a tumor growth signaling. COPD-induced signals may be susceptible to prevention or treatment with VEGFR-2 and EGFR inhibitors.
Researchers will analyze thousands of small molecules and measure changes in metabolite expression using state-of-the-art mass spectrometry technology. The study aims to identify metabolic changes linked to ciliopathy development and the pathogenesis of COPD, potentially leading to new biomarkers and therapeutic treatments.
Researchers have identified a new strategy to thin thick mucus in cystic fibrosis and COPD using the SPLUNC1 protein and its synthetic derivatives. This may lead to improved mucus clearance and better lung function for those affected.
A new study found that people with chronic obstructive pulmonary disease (COPD) who report high levels of fatigue are at increased risk of hospitalization. The researchers assessed 83 patients attending a pulmonary rehabilitation clinic, reporting a strong association between reported fatigue and severity of COPD.
Prior ICS treatment before CAP diagnosis is associated with lower incidence and severity of parapneumonic effusion. Patients treated with ICS had a significantly lower risk of developing this complication, regardless of their baseline chronic respiratory condition.
Researchers found that P. aeruginosa infection is associated with worse clinical outcomes, including more hospitalizations, ICU admissions, and exacerbations in COPD patients. The study suggests that addressing P. aeruginosa infections may be crucial in managing COPD.
A new study by researchers at the Centers for Disease Control and Prevention found that residents of Lower Manhattan who suffered home damage following the 9/11 attacks are more likely to report respiratory symptoms and diseases. The study analyzed data from over 71,000 survivors of the World Trade Center attacks, including those with ...
A significant percentage of COPD patients (44%) report troublesome dyspnea during sexual activity, limiting their sex life. Depression and poor well-being are also prevalent among both COPD and heart failure patients, with high levels reported in the study.
A new study from the UK shows that completion of pulmonary rehabilitation significantly improves survival in patients with chronic obstructive pulmonary disease (COPD). Patients who completed rehabilitation had a higher level of response in exercise capacity and a significant survival advantage compared to those who did not complete re...
A new study found that nearly all COPD patients have two or more comorbidities, with most having four or more. The presence of these comorbidities can complicate treatment and affect patient outcomes. Future guidelines should address the management of comorbidities in COPD patients.
A recent study found that male patients with pulmonary disease have a very high risk of osteopenia/osteoporosis, which can be reduced by routine screening and early intervention. The study included 46 patients, most of whom were male, and showed that those with more severe lung disease are more likely to also have bone disease.
A small clinical trial suggests that acupuncture improves dyspnea and health-related quality of life in patients with chronic obstructive pulmonary disease. After 12 weeks of treatment, the Borg scale score improved from 5.5 to 1.9 in the real acupuncture group.
Researchers found that a comprehensive care management program for chronic obstructive pulmonary disease (COPD) may not be safe or suitable for patients, as it led to excess mortality. In contrast, laxative-free colonography proved accurate in detecting most significant lesions and eliminated a major barrier to colon cancer screening. ...
A new study found that comorbidities are independently associated with an increased mortality risk in COPD patients. The study identified 12 comorbidities, including lung cancer, pancreatic cancer, and congestive heart failure, as significantly increasing the risk of death.
Researchers at UC Irvine found that moderate to severe COPD patients with low heart disease risk had a significantly better prognosis. The study suggests addressing cardiac risk factors can improve outcomes in people with COPD, and highlights the importance of cardiovascular health for lung disease patients.
Researchers found that PAX5 stabilizes MYC protein levels in B cells, correlating with poor patient survival. Additionally, STIM1 regulates calcium signaling to control fat preference, while IL-12 production is decreased in diabetic patients with increased infection risk.
A Canadian study found opioids significantly improved the quality of life and relief from shortness of breath for advanced COPD patients. However, physicians were hesitant due to lack of guidance, fear of respiratory suppression, and concerns about censure. Innovative educational initiatives may help bridge this gap in care.
Scientists have discovered that immune cells circulating in the blood enter the lungs' large airways, triggering inflammation and oxidative stress. This breakthrough helps clarify how smoking causes severe respiratory damage and may lead to new treatments.
A recent study found that adding inflammatory biomarkers improves the clinical prediction of mortality in patients with chronic obstructive pulmonary disease (COPD). The addition of a panel of selected biomarkers significantly improved the ability of clinical variables to predict mortality, with a C-statistic of 0.726.
A new study reveals that children exposed to passive smoke have a nearly double risk of developing chronic obstructive pulmonary disease (COPD) in adulthood compared to non-exposed children. Childhood exposure was found to be a stronger risk factor for COPD and related symptoms than adult exposure.